Compare Adaptive Biotechnologies Corp (ADPT) vs IONQ Inc (IONQ) Price & Performance

ADPT trades at $24.94, down 2.0% today but near its 52-week high. The stock shows a bullish technical trend with improving fundamentals, including 49% MRD revenue growth and narrowing losses. A recent 4:1 reverse stock split and planned business separation aim to unlock value, with analyst consensus leaning bullish.

Outlook is cautiously optimistic due to strong revenue growth and margin expansion, but risks persist from ongoing net losses and competitive pressures. The stock offers potential upside to the $25.50 consensus target if execution continues improving, yet volatility may remain until profitability is achieved.

IONQ trades at $44.82, up 5.38% with a bullish technical signal supported by moving averages. The quantum computing company reported explosive 287% revenue growth in Q2 2026 to $80.1 million and raised its full-year outlook, though it remains deeply unprofitable with a -553% net margin. Recent catalysts include a $28 million DARPA contract extension and strong analyst sentiment with a $73.33 consensus price target representing 64% upside potential.

While IONQ demonstrates exceptional revenue momentum and technological leadership in quantum computing, investors face substantial risk from persistent losses, high cash burn, and valuation multiples exceeding 60x sales. The stock offers significant growth potential but requires tolerance for volatility and a long-term horizon given the nascent stage of quantum commercialization.